Leukemia, Lymphoblastic, Acute Clinical Trial
Official title:
Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia
Philadelphia-chromosome-positive or partial ph-like acute lymphoblastic leukemia (ALL) preferred chemotherapy combined with tyrosine kinase inhibitors (TKIS) therapy. Recently we found that there were cytomegalovirus reactivation and even cytomegalovirus infection in three ALL patients treated with chemotherapy combined with TKIs. However, the cytomegalovirus risk after dasatinib use in patients with philadelphia-chromosome-positive ALL is still unknown. It is reported that dasatinib can be observed in the treatment of philadelphia-chromosome-positive leukemia patients with significant increase in large granular lymphocytes, the cytomegalovirus is often positive, and this part of the patient's prognosis is relatively good. Dasatinib can inhibit SRC and TEC kinase, and induce immune function inhibition,and in vitro experiments have confirmed that it inhibits the immune function of T cells and NK cells. In this study, we examined the potential association between cytomegalovirus AND EBV reactivation the treatment of chemotherapy combined with TKIs, and the numbers of large granular cells and NK cell activity.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00916045 -
Pilot Study of Unrelated Cord Blood Transplantation
|
Phase 2 | |
| Completed |
NCT00458250 -
Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H
|
Phase 1 | |
| Completed |
NCT02264873 -
Phase I, Dose Escalation Study of Decitabine
|
Phase 1 | |
| Recruiting |
NCT01015742 -
Unrelated Double Umbilical Cord Blood Units Transplantation
|
Phase 2/Phase 3 | |
| Completed |
NCT00475280 -
"Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients
|
Phase 2 | |
| Terminated |
NCT01100658 -
Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors
|
N/A | |
| Completed |
NCT00241358 -
Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies
|
Phase 1/Phase 2 | |
| Completed |
NCT01976442 -
Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia
|
N/A | |
| Recruiting |
NCT00619879 -
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
|
Phase 3 | |
| Completed |
NCT00179764 -
Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
|
N/A | |
| Terminated |
NCT01045382 -
MSC and HSC Coinfusion in Mismatched Minitransplants
|
Phase 2 | |
| Completed |
NCT00186901 -
A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors
|
Phase 3 | |
| Completed |
NCT00859586 -
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
|
N/A | |
| Terminated |
NCT00539656 -
Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers
|
Phase 1/Phase 2 | |
| Terminated |
NCT01186328 -
EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
|
Phase 1 | |
| Terminated |
NCT01158885 -
Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia
|
Phase 2 | |
| Completed |
NCT02888990 -
Dasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic Leukemia
|
Phase 2 | |
| Completed |
NCT03627208 -
Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch
|
||
| Recruiting |
NCT03235973 -
Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes
|
Phase 1 |